2019
DOI: 10.3390/medicina55050170
|View full text |Cite
|
Sign up to set email alerts
|

Case Report of Misleading Features of a Rare Sertoli Cell Testicular Tumor

Abstract: Testicular Sertoli cell tumors are extremely rare. Generally, they are benign neoplasms, which belong to a group called sex cord–stromal tumors. In this article, we present a case report of a Sertoli cell tumor, which was accidentally discovered during a urological consultation of a 42-year-old male. An ultrasound showed a 2.1 × 2.2 cm hypoechogenic, hypervascular tumor in the middle third of the left testicle. Serum tumor markers (α-fetoprotein, alkaline phosphatase, β-human chorionic gonadotropin, and lactic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 8 publications
(7 reference statements)
0
2
0
Order By: Relevance
“…Sertoli cell tumors are mostly of benign characters; however, an in-depth literature analysis shows cases with malignant behavior. Generally, the aggressive attitude was estimated to be observed in 10-22% of these tumors (11). Sertoli cell testicular tumors are rarely observed, thus no strict follow-up and treatment protocols are available.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Sertoli cell tumors are mostly of benign characters; however, an in-depth literature analysis shows cases with malignant behavior. Generally, the aggressive attitude was estimated to be observed in 10-22% of these tumors (11). Sertoli cell testicular tumors are rarely observed, thus no strict follow-up and treatment protocols are available.…”
Section: Discussionmentioning
confidence: 99%
“…However, various aggressive treatment strategies, such as retroperitoneal lymph node dissection, chemotherapy, and radiation therapy combinations, are applied in cases that show remote organ dissemination (13). Survival rates for 1 and 5 years were estimated as 93 and 77% for Stage 1 Sertoli cell tumors, respectively (11). Contrarily, late metastases were reported in some cases at stages up to 10 years (14).…”
Section: Discussionmentioning
confidence: 99%